• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

hyperkalaemia - Articles and news items


FDA to re-review application for AstraZeneca’s hyperkalaemia treatment

Industry news / 18 October 2016 / Niamh Louise Marriott, Digital Content Producer

Hyperkalaemia (potassium levels > 5.0 mEq/L in the blood serum) occurs in patients with advanced chronic kidney disease and chronic heart failure…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +